Editorial Note: Malaysian researchers
NMN/NAD+ research community | Various institutions
About
As of 2026, Malaysian primary NMN clinical research is limited - most cited human trials originate from US, Japan, China, and Europe. Malaysian-led work on NAD+ biology comes primarily from Universiti Malaya, Universiti Kebangsaan Malaysia, and IMU Health science faculties. NMN Malaysia tracks Malaysian publications and will profile individual researchers as the local research base grows.
Key contributions
- Malaysian NAD+ research tracking
- Local publication monitoring
- Future Malaysian researcher profiles
Why their work matters for Malaysian buyers
Editorial Note: Malaysian researchers's research forms part of the evidence base we use to evaluate NMN and NR products available in Malaysia. When we make claims about dose ranges, safety, mechanism, or efficacy on this site, those claims trace back through papers like the ones above. The Malaysian regulatory framework (NPRA notification, JAKIM halal certification) does not perform efficacy review on supplements - buyers must do their own evidence weighting. Researcher profiles help you verify that the underlying science is robust, not just marketing.
How we cite this work
Every NMN Malaysia article that depends on findings from Editorial Note: Malaysian researchers's lab carries an inline citation linking to a structured PubMed entry. You can verify any claim by clicking the citation and reading the source. This cited-research model is the bedrock of our editorial policy - see the 4-step review process for how we handle every health claim.
Related researchers
Browse other profiles: David Sinclair | Shinichiro Imai | Jun Yoshino | Charles Brenner | all profiles.